Press release -
MiniTEM contributes to the success of our customers
The event at Cell & Gene Therapy in Amsterdam this week was a successful showcase for MiniTEM. Apart from our own activities at our booth and a presentation in the main program we also received an excellent testimonial from Hanna Lesch, Research and Development Director at Finvector. She described the implementation of MiniTEM technology for analytical testing in their R&D department, in partcular for purification testing during downstream processing. She pointed out that the key tool and the strength of MiniTEM is its automation and how easily it recognizes different shapes and debris from the primary particles. Nothing gives us more satisfaction than seeing our analytical solutions contribute to the success of our customers.
Topics
- Medical research
Categories
- vironova
- minitem
Vironova is a Swedish biotechnology company providing comprehensive, hardware, software and services for the analysis of nanoparticles. Vironova revolutionizes access to transmission electron microscopy (TEM)-based image analysis in biopharmaceutical development. Our solution enables automated analyses for faster and better-informed decisions to secure robust bioprocessing and final product quality.
The Vironova offering comprises:
- Cost effective, fast Electron Microscopy (EM) services enabled by the in-house developed Vironova Analyzing Software (VAS) designed for semi-automated nanoparticle analysis
- Viral clearance testing performed in GLP and BSLIII certified laboratories
- MiniTEM™, a bench-top Transmission Electron Microscope system designed for automated nanoparticle characterization. High-resolution images reveal particle morphologies that are transformed into accurate metrics.
